Table of Content

1 Market Introduction
1.1 Market Definition
1.2 Research Scope and Segmentation
1.3 Stakeholders
1.4 List of Abbreviations


2 Executive Summary


3 Research Methodology
3.1 Identification of Data
3.2 Data Analysis
3.3 Verification
3.4 Data Sources
3.5 Assumptions


4 Market Dynamics
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Market Challenges


5 Porter’s Five Force Analysis
5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Buyers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry in the Market


6 Global Radiation Oncology Market by, Type
6.1 Overview
6.2 Internal Beam Radiation Therapy
6.2.1 Brachytherapy
6.2.2 Systemic Beam Radiation Therapy
6.2.3 Other Internal Beam Radiation Therapies
6.3 External Beam Radiation Therapy
6.3.1 Linear Accelerators (Linac)
6.3.2 Compact Advanced Radiotherapy Systems
6.3.3 Proton Therapy


7 Global Radiation Oncology Market by, Application
7.1 Overview
7.2 Prostate Cancer
7.3 Breast Cancer
7.4 Lung Cancer
7.5 Head and Neck Cancer
7.6 Colorectal Cancer
7.7 Cervical Cancer
7.8 Gynecological Cancer
7.9 Other Applications


8 Global Radiation Oncology Market by, End User
8.1 Overview
8.2 Hospitals
8.3 Cancer Research Institutes
8.4 Other End Users


9 Global Radiation Oncology Market by, Geography
9.1 Overview
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 UK
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 South Korea
9.4.5 Australia
9.4.6 New Zealand
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 UAE
9.6.2 Saudi Arabia
9.6.3 Qatar
9.6.4 Iran
9.6.5 South Africa
9.6.6 Rest of Middle East & Africa


10 Key Developments


11 Company Profiling
11.1 Accuray Incorporated
11.1.1 Business Overview
11.1.2 Product/Service Offering
11.1.3 Financial Overview
11.1.4 SWOT Analysis
11.1.5 Key Activities
11.2 BD (Becton, Dickinson and Company)
11.3 Curium
11.4 Elekta AB
11.5 IBA Radiopharma Solutions
11.6 Isoray Inc.
11.7 Mevion Medical Systems
11.8 Nordion, Inc.
11.9 NTP Radioisotopes SOC Ltd.
11.10 Provision Healthcare
11.11 Varian Medical Systems, Inc.
11.12 ViewRay Technologies, Inc.